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ABSTRAK 
 
Keracunan Amitraz jarang berlaku dan kes ini tidak pernah dilaporkan dalam kajian di 
Malaysia.  Pengambilan bahan ini membawa kepada kesan sampingan yang 
membahayakan nyawa. Kami melaporkan satu kes keracunan Amitraz yang berlaku 
pada seorang dewasa berumur 18 tahun. Beliau mengalami hipotensi dan 
memerlukan sokongan pernafasan serta jagaan seharian dalam unit intensif. Beliau 
telah diberi rawatan berlandaskan simptom di bawah pengawasan rapat dan telah 
sembuh dengan cepat dan dibenarkan balik selepas 3 hari.    
  
Kata kunci: amitraz, keracunan, dewasa 
 
ABSTRACT  
 
Amitraz poisoning is rare and there has been no reported cases in the Malaysian 
literature. Ingestion of this compound carries many life threatening side effects. We 
describe a case of Amitraz poisoning in an 18 years old young adult. He developed 
hypotension, required ventilatory support and a day of intensive care unit stay. He had 
a quick recovery after he was treated symptomatically and was discharged well after 3 
days. 
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INTRODUCTION  
 
Amitraz is a synthetic compound, widely 
used in veterinary medicine as an 
insecticide and acaricide. The IUPAC 
name is 1,5 di-(2, 4-dimethylphenyl)-3-
methyl-1,3, 5-triaza-penta-1, 4-diene, a 
member of the formamidine pesticide 
group. It is generally used as a treatment 
for control of ticks and mites in dogs 
(Shitole et al. 2010). Only a handful of 
Amitraz poisoning cases are reported in 
the literature and to date, no such cases 
are described in the Malaysian literature. 
We report a case of amitraz poisoning 
and review the clinical features and 
management of his condition. 
 
CASE REPORT 
 
A healthy 18 year-old man had ingested 
an approximately 100ml of undiluted anti 
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flea shampoo for dogs in a suicidal 
attempt. He was brought into the 
Emergency Department an hour after 
ingestion with an initial blood pressure of 
115/60 mmHg and a pulse rate of 110 
beats per minute. He was alert with a 
Glasgow Coma Scale (GCS) score of 
15/15 and a blood capillary glucose of 
5.4 mmol/L. However, he was noted to 
be drowsy an hour after admission with a 
reduced GCS score of 8/15. His blood 
pressure also plummeted to 75/40 mmHg 
with a pulse rate of 60 beats per minute. 
Accordingly, he was intubated for airway 
protection and started on inotropic 
support (noradrenaline). Blood tests 
revealed normal renal and liver function. 
He was normoglycemic throughout. 
Toxicology screen for other poisons were 
negative. 
After inotropic support was tapered off 
within 8 hours, his condition improved 
over the next three days and was 
subsequently discharged well. 
 
DISCUSSION 
 
Amitraz is a potent α2-adrenergic agonist. 
Stimulation of central α2-adrenergic 
receptors results in hypotension and 
bradycardia (Jones 1990). Common 
clinical presentations include central 
nervous depression ranging from 
drowsiness to coma (Bonsall et al. 1983). 
Other reported effects of Amitraz 
poisoning are hyperglycemia, 
hypothermia and convulsions (Leung et 
al. 1999). Organophosphates, opiods and 
drugs that act at α2-adrenergic receptors 
such as clinodine can also present 
similarly and might lead to diagnostic 
confusion. The reported time from 
ingestion to the onset of signs and 
symptoms is about 30 to 90 minutes. The 
duration of recovery varied from 2 to 48 
hours after presentation (Avşaroğullari et 
al. 2006). Our patient had central 
nervous depression with hypotension and 
bradycardia two hours after ingestion 
which was consistent with Amitraz’s 
effects. He had a relatively quick 
recovery and his condition improved a 
day after ingestion. However, there was 
neither hyperglycemia nor hypothermia in 
him. Clinical features such as 
unconsciousness, hypotension and 
bradycardia requiring mechanical 
ventilation were described in similar 
cases (Shitole et al. 2010). Yilmaz et al. 
has also described severe respiratory 
depression requiring mechanical 
ventilation for less than 24 hours.  
Treatment of Amitraz poisoning is 
mainly supportive and symptomatic. 
There is no specific antidote for this 
poisoning (Yilmaz et al. 2003). In some 
animal studies, α2-adrenergic antagonists 
such as yohimbin and atimepazole 
reversed most of the signs in Amitraz 
poisoning. However, these antagonists 
have never been used in humans and 
should only be considered in severe 
cases (Avşaroğullari et al. 2006). The 
main goal of management in Amitraz 
poisoning is airway clearance with 
adequate ventilation in cases of impaired 
consciousness. Inotropic agents 
(dopamine and noradrenaline) may be 
required in hypotensive patients who are 
not responsive to fluid challenges 
(Avşaroğullari et al. 2006). Atropine may 
be useful for treating hemodynamically 
unstable bradycardia (Jones 1990). 
Despite a life threatening clinical picture, 
Amitraz poisoning in humans carries a 
low mortality when appropriate 
supportive therapy is given (Shitole 
2010). 
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